Showing results (251-260 of 268) with videos related to
Sort By:
Pageof 27
Cancer|April 1, 1990
A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancerT E Elliott, C G Moertel, H S Wieand, et al.Cancer Treatment Reports|July 1, 1978
Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancerR G Hahn, N R Temkin, E D Savlov, et al.Medical and Pediatric Oncology|January 1, 1989
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group studyD S Ettinger, D M Finkelstein, R C Donehower, et al.Cancer|July 1, 1977
A phase II study of triazinate (NSC 139105) in advanced colorectal carcinomaR H McCreary, C G Moertel, A J Schutt, et al.Cancer|November 1, 1992
A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancerC M van Haelst-Pisani, R L Richardson, J Su, et al.Journal of Interferon Research|December 1, 1992
Phase II trials of interferons-alpha and -beta in advanced sarcomasE C Borden, K Kim, L Ryan, et al.The Journal of Thoracic and Cardiovascular Surgery|January 1, 1985
Malignant germ cell tumors of the mediastinumR H Knapp, R D Hurt, W S Payne, et al.Cancer|December 1, 1975
An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristineD L Ahmann, H F Bisel, R G Hahn, et al.Cancer Clinical Trials|January 1, 1978
Evaluation of a fixed alternating treatment in patients with advanced breast cancerD L Ahmann, J O'Fallon, M J O'Connell, et al.Investigational New Drugs|June 1, 1988
Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinomaP J Elson, L K Kvols, S E Vogl, et al.Pageof 27